Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
Liying Ma, Xing Bian, Wenchu Lin
Abstract
An amendment to this paper has been published and can be accessed via the original article.
Topics & Concepts
OlaparibPARP inhibitorCancer researchDual (grammatical number)Lung cancerChemistryPoly ADP ribose polymeraseComputer scienceMedicineInternal medicineBiochemistryPhilosophyLinguisticsGenePolymeraseLung Cancer Research StudiesHistone Deacetylase Inhibitors ResearchCancer therapeutics and mechanisms